TP53 and hepatocellular carcinoma: Growth of HepaMP9-1 cells, a murine HCC cell line driven by constitutive MYC overexpression and p53 loss (MYCOE; Trp53KO), was also impaired by dose-dependent JQ-1 or ABBV075 treatment (Supplementary Fig. S5c).